N‒substituted 5‒hydroxy‒pyrrol‒2‒ones based cholecystokinin‒2 antagonists as experimental anticancer agents for the treatment of lung cancer

Eric Lattmann, Steven T Russell, Mankaran Singh, Ramesh Narayanan, Padinjarethalakal N. Balaram, Pornthip Lattmann

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'N‒substituted 5‒hydroxy‒pyrrol‒2‒ones based cholecystokinin‒2 antagonists as experimental anticancer agents for the treatment of lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry